Quick navigation menu :

  1. Go to content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. Global Business Websites |
     
  3. Contact Us |
  4. Sitemap |
  5. Help
  1. Font size

    Reduce Increase  
 
 

Your Health

Contact Us

sanofi-aventis Pakistan limited

Registered Office

Plot 23, Sector 22
Korangi Industrial Area
Karachi-74900

Postal Address

P.O. Box 4962
Karachi-74000

Tel: +92-21-35060221-35

Content :

Vaccines

 

Vision

Immunization saves more than 2.5 million lives every year in all age groups from diphtheria, tetanus, pertussis and measles – but more than 2 million people still die due to lack of access to vaccines.

Our vision is a world in which no one suffers or dies from a vaccine-preventable disease.

To achieve our vision, we rely on cooperation, innovation and education. Informing the public about the burden of disease and the true value of vaccines will help maintain and develop greater immunization coverage, and as a result, save lives.

 

Key Facts

A global company:

  • Headquarters: Lyon, France
  • Revenue: €3,483 million in 2009 (+19.2% compared to 2008 at constant exchange rates)
  • More than 12,500 employees worldwide

Investment in research and production capacity:

  • More than 1.6 billion doses of vaccines produced yearly to immunize more than 500 million people in the world
  • Largest product range available, against 20 infectious diseases
 

The Value of Vaccines

“Immunization has been a great public health success story. The lives of millions of children have been saved, millions have the chance of a longer healthier life, a greater chance to learn, to play, to read and write, to move around freely without suffering”.
Nelson Mandela, winner of the Nobel Peace Prize, 1993

Disease prevention is the most cost-effective health-care intervention available. Because immunization helps to inhibit the spread of disease, many people can be protected from illness and death. With the exception of clean, safe drinking water, no human endeavor rivals immunization in combating infectious diseases and reducing mortality rates.

Vaccines: A key strategic focus

Sanofi Pasteur, the vaccine division of Sanofi group, is the largest company in the world devoted entirely to human vaccines. To prevent diseases in children, adolescents and adults around the world, the Sanofi Pasteur R&D team is developing new generations of vaccines. Sanofi Pasteur offers the widest range of vaccines for 20 diseases.

With tomorrow’s health challenges in view, the R&D team of sanofi pasteur, the Group’s Vaccines division, is working on both innovation and improvement of vaccine delivery and modes of administration. Either alone or in partnership, the research team is attacking such major diseases as dengue, pneumococcal infections, cytomegalovirus, malaria, tuberculosis, Chlamydia and Type B meningitis. In addition, sanofi pasteur remains at the forefront of influenza pandemic preparedness.

Dengue fever

Dengue fever is the second-most widespread tropical disease after malaria in mosquito-borne diseases. Each year, 50 to 100 million people around the world are infected and at present there is neither vaccine against it nor any specific treatment. Sanofi Pasteur scientists have been engaged in the research and development of a preventive vaccine against dengue. In February 2009, sanofi pasteur’s tetravalent vaccine project, in partnership with the WHO, entered a critical stage with the start of its large-scale Phase III efficacy trial in Thailand. The vaccine is expected to be available in 2012.

Vaccines provide an effective response to major diseases, generally as a preventive measure but sometimes as a therapeutic solution. Seasonal influenza, for example, is a constant concern for health authorities throughout the world, and sanofi pasteur is the undisputed leader in the field of influenza prevention. Sanofi Pasteur continued to bring innovative, effective and easier-to-use vaccines to market.

 

Our Vaccines:

Today, according to the World Health Organization (WHO), vaccines are available to protect against more than 26 infectious diseases.

Sanofi Pasteur has the broadest available range of vaccines, protecting against 20 infectious diseases

  • World’s largest producer of influenza vaccines: over 170 million doses provided in 2008
  • World’s leading provider of poliomyelitis vaccine
  • Broadest range of modern pediatric combination vaccines for children throughout the world
  • World’s largest provider of meningococcal vaccines with an unfaltering commitment to provide meningococcal vaccine to fight epidemics in Africa
  • Largest portfolio of vaccines for travelers and people living in tropical areas: typhoid, rabies, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, hepatitis A, hepatitis B
 

During 2008, a new business unit was set up in sanofi-aventis Pakistan to handle the vaccines business in Pakistan. Sanofi Pasteur has a product portfolio that offers protection against 20 infectious diseases that include:

For more information regarding our vaccines business, please visit: www.sanofipasteur.com

Travel Vaccines:

Module :